Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. - Wikidata - awgldk - TriplyDB

Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.

Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.

http://www.wikidata.org/entity/Q46067245

about

Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy.Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiency The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer Pre-targeting and direct immunotargeting of liposomal drug carriers to ovarian carcinoma Lipid-based vectors for siRNA delivery Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Bionanotechnology and the future of glioma.Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy.Combinatorial peptide libraries: mining for cell-binding peptides.Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies.Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells.Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodies Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting.Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect.Synthesis and preliminary biological evaluation of high-drug-load paclitaxel-antibody conjugates for tumor-targeted chemotherapy Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes.Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic Efficient and targeted delivery of siRNA in vivo.Immunoliposomal delivery of 213Bi for alpha-emitter targeting of metastatic breast cancer.The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications.Accelerated killing of cancer cells using a multifunctional single-walled carbon nanotube-based system for targeted drug delivery in combination with photothermal therapy.Intratumoral drug delivery with nanoparticulate carriers.Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity Engineering polymeric aptamers for selective cytotoxicity.Imaging, autoradiography, and biodistribution of (188)Re-labeled PEGylated nanoliposome in orthotopic glioma bearing rat model.Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models.Exploring Different Strategies for Efficient Delivery of Colorectal Cancer Therapy Ligands located within a cholesterol domain enhance gene delivery to the target tissue.Emerging monoclonal antibody therapies for malignant gliomas.Use of nanoparticles for drug delivery in glioblastoma multiforme.Surface-active liposomes for targeted cancer therapy.Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.Antibody-targeted liposomes in cancer therapy and imaging.Nanotechnology-novel therapeutics for CNS disorders

P2860

Q24616751-6DC13CDA-5262-4FD7-93B7-41382D58A302 Q24642374-61DA390D-17E4-4322-8012-EAC567F0DCBB Q24646373-0C8E883B-56DC-40CF-B8D5-BC944B24D232 Q26827999-75CBC676-3989-4151-BE95-0FAF758112D9 Q27015045-480C8396-508F-448D-BEC5-8C06C1460752 Q27308658-BB7916EA-E7EE-49E4-B36C-17DC040E5B8E Q28291499-361FA1D0-24E4-4903-A0AE-0DEFF911B365 Q28481572-616E4C68-3DCB-41A8-AF59-AD7EC317FB97 Q28828356-0DBE6389-202C-4407-B60A-C14096F5D402 Q30366990-27333FC3-68C0-4617-8B95-E755A3AC2BDB Q30417964-91405187-687D-4698-B25F-F4AE842522B3 Q30421668-29666CEA-A007-4DB5-850E-817C22E28A21 Q31144876-1D3C6BC5-DABD-4F9C-A9EE-2F736E3D9D8A Q33284494-EF2DAC88-9823-4EEA-B2D4-7306DE1B01A7 Q33289414-81C983D8-29DA-484D-87BC-BBA4F86172FA Q33322420-6E9F2903-8DE5-4404-8E90-7CE3D4B5D524 Q33520512-3834E297-DA87-419D-9529-E7502A649D6B Q33604955-BCCEA9CA-8303-48CA-931D-5DDA8015A02A Q33689872-649B4EC4-07E4-4516-BC8D-CBD940402640 Q33737986-5B7797CE-2ED9-4697-AE4B-2F8B47E392AD Q33802940-64C3AB83-D609-4A72-974D-DB98C351E7A2 Q33811463-2D38C97C-E9BB-4C1D-9CB1-63A2F834A9A2 Q33911056-25967ABF-0B60-40E8-A2F0-98EB2BAD3542 Q34149828-2EA04890-7CD7-454C-8886-ED9962879AB6 Q34296503-BE24AB3A-045D-48B5-AB59-302F394C7771 Q34610495-6B028AEB-829A-4907-9680-E1165D1216F8 Q34910276-AAC54076-05F0-4D2B-B9F1-29D74C57CCAB Q35091415-2C6786B8-D86A-4303-9E00-DA2FE5C943C8 Q35234721-1E3546ED-95AA-4BA0-BD77-4335FCC591BC Q35308685-CB789152-C6C0-40DE-843C-B94D08C1B93E Q35595546-EA402E4E-7A27-4515-84CA-5FCB632623FD Q35674222-AD5585A6-05B1-4914-8F1B-9808F8C7DC3A Q36324618-51559CB7-86DD-4CB9-9ADB-26429DC51E87 Q36755139-F4F971DC-7E80-4782-BF60-6C66934857B7 Q36764016-88947BB3-8B32-4903-9FDB-1BDC7340BD49 Q36787338-93AC3A20-67D8-41EA-BE1A-357A0E2D0FD5 Q36988355-578F6DE4-BD52-49CD-8295-C1F2FC64C7BE Q37033793-599FA65C-BE2C-4BB1-A638-5FEAAAE6D021 Q37076367-47111E70-2678-4A42-A5DC-F7DD231D769C Q37173643-C54C60AA-5512-496E-9963-9498EBABD564

P2860

Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.

http://www.wikidata.org/entity/Q46067245

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Epidermal growth factor recept ...... iple anticancer drugs in vivo.

@en

Epidermal growth factor recept ...... iple anticancer drugs in vivo.

@nl

type

label

Epidermal growth factor recept ...... iple anticancer drugs in vivo.

@en

Epidermal growth factor recept ...... iple anticancer drugs in vivo.

@nl

prefLabel

Epidermal growth factor recept ...... iple anticancer drugs in vivo.

@en

Epidermal growth factor recept ...... iple anticancer drugs in vivo.

@nl

P1433

Q46067245-44D32BA4-9503-4F7D-9E2C-9C35D31B4A8B

P1476

Q46067245-D33A2F96-E945-4703-B214-E9401FEDBB3F

P2093

Q46067245-135D392F-6997-42CC-B8DD-0BFF9785208E

Q46067245-30ACB595-E5BD-4CBA-87D3-8E553FD0AC1E

Q46067245-859D1132-D0DF-48A7-8629-BDFDB5D0ED9C

Q46067245-D13D821C-7590-46E5-9843-9B3C3C65EC45

Q46067245-D6D88B1E-F97A-463C-BD81-39EBFDF54DA9

Q46067245-DD91CE42-AFBB-4C9B-852B-98EDCA57A4C9

P304

Q46067245-85D4E9D0-6D04-49BE-B8CF-1473AE684495

P31

Q46067245-C05A6FEE-95D8-4858-8E6A-5C36148B870E

P356

Q46067245-B99EB0F2-BF47-4761-8CCD-C13A6441CB4D

P407

Q46067245-3B715BA4-D655-4864-987F-442E346F4847

P433

Q46067245-6887CFDF-7428-42AA-BBF3-89611D5BE109

P478

Q46067245-5392FEA0-F71F-4373-9F99-2120D5CE94DA

P50

Q46067245-5D1451AA-930A-421E-B14B-0E63BF161639

Q46067245-7A922312-C27F-48BE-A6BF-A4949F60E515

P577

Q46067245-6A8A297E-DB49-4FBB-B164-3864E338CE93

P698

Q46067245-D7DE51E9-1E85-4B61-BDBA-8EF100E1E163

P356

0008-5472.CAN-05-1093

P1433

Cancer Research

P1476

Epidermal growth factor recept ...... iple anticancer drugs in vivo.

@en

P2093

Charles O Noble

http://www.w3.org/2001/XMLSchema#string

Daryl C Drummond

http://www.w3.org/2001/XMLSchema#string

John W Park

http://www.w3.org/2001/XMLSchema#string

Keelung Hong

http://www.w3.org/2001/XMLSchema#string

Verena Kallab

http://www.w3.org/2001/XMLSchema#string

Zexiong Guo

http://www.w3.org/2001/XMLSchema#string

P304

11631-11638

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-05-1093

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Dmitri B. Kirpotin

Christoph Mamot

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16357174

http://www.w3.org/2001/XMLSchema#string